Immune responses to biologics for psoriatic arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at how your immune system responds to biologic medications used to treat psoriatic arthritis. If you are starting a new biologic, you may be able to join and help researchers understand which treatments work best for different people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a doctor-confirmed diagnosis of psoriatic arthritis.
- You must be starting a new biologic or targeted medication for your psoriatic arthritis.
- You cannot have taken the exact same medication before.
- You must be willing to give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized treatment plan can help people with psoriasis and psoriatic arthritis, and also looks at how these conditions affect the heart. The goal is to find better ways to treat you and protect your heart health.
This study uses advanced testing to understand inflammation in people with certain chronic inflammatory diseases, such as psoriasis, psoriatic arthritis, other types of arthritis, or inflammatory bowel disease. The goal is to tailor treatment to your specific needs.
This trial looks at how different biologic treatments work when used one after another for people with plaque psoriasis. It may help find the best order of treatments to keep your skin clear.
This registry is collecting information about people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis who are starting or needing biologic or targeted medicines. It may help researchers better understand how these treatments work in real life.
This study looks at whether starting biologic treatments early, even before joint pain appears, can help people with psoriasis who have signs of joint inflammation on ultrasound. You may be eligible if you have moderate to severe psoriasis but no joint symptoms yet.
This study compares two “treat-to-target” strategies for psoriatic arthritis. One strategy uses imaging to guide treatment changes, and the other uses standard clinic assessments, to see which approach controls symptoms more effectively.
Hear when a new Psoriasis Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.